Search results
BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings Estimates
Zacks via Yahoo Finance· 4 days agoBioMarin (BMRN) delivered earnings and revenue surprises of 18.33% and 0.14%, respectively, for the...
Is a Surprise Coming for BioMarin (BMRN) This Earnings Season?
Zacks· 6 days agoThis suggests that analysts have very recently bumped up their estimates for BMRN, giving the stock a Zacks Earnings ESP of +21.30% heading into earnings ...
Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) Rose 8.64% From Its 52-Week Low, But YTD Numbers Fell...
Marketing Sentinel· 3 days agoThe stock’s 5-day price performance is -7.62%, and it has moved by -5.16% in 30 days... Pharmaceutical Inc. (BMRN) estimates and forecasts ...
Gear Up for BioMarin (BMRN) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks· 7 days agoBesides Wall Street's top -and-bottom-line estimates for BioMarin (BMRN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
BioMarin (BMRN) Beats on Q1 Earnings, Voxzogo Drives Sales
Zacks via Yahoo Finance· 3 days agoBioMarin's (BMRN) earnings beat estimates in the first quarter of 2024, while revenues slightly miss...
BioMarin Pharmaceutical, Inc. (BMRN) Q1 2024 Earnings Call Transcript
Seeking Alpha· 4 days agoBioMarin Pharmaceutical, Inc. (NASDAQ:NASDAQ:BMRN) Q1 2024 Earnings Conference Call April 24, 2024 4:30 PM ETCompany ParticipantsTraci McCarty - Head of...
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's...
Benzinga· 3 days agoBioMarin Pharmaceutical Inc . BMRN dipped 9% to $83.05 after the company reported first-quarter financial results. Reliance, Inc . RS fell 8.8% to...AZZ Inc . AZZ dipped 8.6% ...
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 5 days agoYou can uncover the best stocks to buy or sell...AstraZeneca has a Zacks Rank #3. Stock to Consider...
BioMarin Reports Record Financial Results for the First Quarter 2024
The Record Gazette· 4 days agoBioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced financial results for the quarter ended March 31, 2024. By advancing and focusing on these promising ...